South Korea-based Hugel Inc., a leading global medical aesthetics company, has officially launched its botulinum toxin p...
South Korea-based Celltrion, Inc. has announced that the US Food and Drug Administration (FDA) has approved an expanded ...
Two leading scientific organisations based in Korea, the Korea Disease Control and Prevention Agency (KDCA) and Int...
PhnyX Lab, a pioneering GenAI startup transforming how life science companies operate, has announced the successful clos...
South Korea-based Dx&Vx (DXVX) has signed its first-ever global out-licensing agreement since its establishment. DXV...
Which are the new products launched by Connietec at the ICPI Week 2025? ConnieTOP, which was released in ICPI Week 2025...
US-based OSR Holdings, Inc., a global healthcare company advancing biomedical and wellness innovation, has signed a term...
South Korea has emerged as a major player in the global biopharmaceutical landscape, transforming from a generic drug ma...
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and...
DeepQure has announced that South Korea's Ministry of Food and Drug Safety (MFDS) has approved a clinical trial of Hyper...
CorestemChemon, a leading GLP-certified preclinical CRO based in South Korea, has entered into a strategic partners...
Japan-based Astellas Pharma Inc. has agreed on a Memorandum of Understanding (MoU) with the Korea Institute of Star...
365mc, South Korea's leading medical institution specialising in fat reduction treatments, and Israel-based Ra...
South Korea-based startup Illimis Therapeutics has announced the closing of 58 billion KRW ($42 million) Series B financ...
South Korea-based biopharmaceutical company Samsung Bioepis has published a whitepaper titled ‘Solving the Biosimi...
The Bio Investments Group AG (BIG), a Swiss healthcare-technology transfer platform, and South Korea-headquartered Inter...
Health2Sync, Asia's leading digital chronic disease management platform, has announced the successful integration of Sma...
Celltrion has announced that STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo), biosimila...
